MDxHealth Valuation
| MDXH Stock | USD 1.87 0.01 0.53% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. MDxHealth SA ADR secures a last-minute Real Value of $1.57 per share. The latest price of the firm is $1.87. Our model forecasts the value of MDxHealth SA ADR from analyzing the firm fundamentals such as Return On Equity of -2.41, profit margin of (0.50) %, and Current Valuation of 98.62 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting MDxHealth's valuation include:
Price Book 5.4466 | Enterprise Value 98.6 M | Enterprise Value Ebitda (2.73) | Price Sales 1.0927 | Enterprise Value Revenue 1.1643 |
Overvalued
Today
Please note that MDxHealth's price fluctuation is dangerous at this time. Calculation of the real value of MDxHealth SA ADR is based on 3 months time horizon. Increasing MDxHealth's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since MDxHealth is currently traded on the exchange, buyers and sellers on that exchange determine the market value of MDxHealth Stock. However, MDxHealth's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.87 | Real 1.57 | Target 9.5 | Hype 1.87 |
The intrinsic value of MDxHealth's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence MDxHealth's stock price.
Estimating the potential upside or downside of MDxHealth SA ADR helps investors to forecast how MDxHealth stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MDxHealth more accurately as focusing exclusively on MDxHealth's fundamentals will not take into account other important factors: When choosing an evaluation method for MDxHealth SA ADR, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
MDxHealth Cash |
|
MDxHealth Valuation Trend
MDxHealth's real value analysis enables investors to forecast the earnings more efficiently. Using both MDxHealth's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
MDxHealth Total Value Analysis
MDxHealth SA ADR is now anticipated to have valuation of 98.62 M with market capitalization of 92.56 M, debt of 41.27 M, and cash on hands of 40.02 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the MDxHealth fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
98.62 M | 92.56 M | 41.27 M | 40.02 M |
MDxHealth Investor Information
About 12.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 1.53. MDxHealth SA ADR had not issued any dividends in recent years. The entity had 1:10 split on the 14th of November 2023. Based on the key indicators obtained from MDxHealth's historical financial statements, MDxHealth SA ADR is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.MDxHealth Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. MDxHealth has an asset utilization ratio of 54.36 percent. This signifies that the Company is making $0.54 for each dollar of assets. An increasing asset utilization means that MDxHealth SA ADR is more efficient with each dollar of assets it utilizes for everyday operations.MDxHealth Ownership Allocation
MDxHealth SA ADR maintains a total of 49.5 Million outstanding shares. 30% of MDxHealth outstanding shares are owned by institutional investors. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.MDxHealth Profitability Analysis
The company reported the previous year's revenue of 70.19 M. Net Loss for the year was (43.1 M) with profit before overhead, payroll, taxes, and interest of 19.22 M.About MDxHealth Valuation
An absolute valuation paradigm, as applied to MDxHealth Stock, attempts to find the value of MDxHealth SA ADR based on its fundamental and basic technical indicators. By analyzing MDxHealth's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of MDxHealth's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of MDxHealth. We calculate exposure to MDxHealth's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of MDxHealth's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 43.9 M | 46.1 M | |
| Pretax Profit Margin | (0.61) | (0.64) | |
| Operating Profit Margin | (0.39) | (0.41) | |
| Net Loss | (0.61) | (0.64) | |
| Gross Profit Margin | 0.63 | 0.74 |
MDxHealth Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 25.9 M |
MDxHealth Current Valuation Indicators
Valuation refers to the process of determining the present value of MDxHealth SA ADR and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value MDxHealth we look at many different elements of the entity such as MDxHealth's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as MDxHealth, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use MDxHealth's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes MDxHealth's worth.Complementary Tools for MDxHealth Stock analysis
When running MDxHealth's price analysis, check to measure MDxHealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MDxHealth is operating at the current time. Most of MDxHealth's value examination focuses on studying past and present price action to predict the probability of MDxHealth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MDxHealth's price. Additionally, you may evaluate how the addition of MDxHealth to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |